Payment overview · 2025
General Payments
$49,546.59
23 reported records · 1 companies
Healthcare provider profile · identity verified
Sharon Tuckett, MD
Allopathic & Osteopathic Physicians|Internal Medicine · VILLA RICA, GA · NPI 1285607648
Verified facts
What the public records show
CMS Open Payments records show Sharon Tuckett, MD received $49,546.59 in general payments during 2025 across 23 reported records.
Takeda Pharmaceuticals U.S.A., Inc. accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | Unresolved — no canonical attribution shown | $49,546.59 | 100.0% | 23 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Consulting Fee | $49,546.59 | 23 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 466 | 112 |
| Amlodipine Besylate | Amlodipine Besylate | 449 | 131 |
| Atorvastatin Calcium | Atorvastatin Calcium | 448 | 131 |
| Omeprazole | Omeprazole | 295 | 86 |
| Gabapentin | Gabapentin | 256 | 65 |
| Losartan Potassium | Losartan Potassium | 231 | 62 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 207 | 63 |
| Citalopram Hbr | Citalopram Hydrobromide | 198 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 194 | 53 |
| Ozempic | Semaglutide | 192 | 34 |
| Lisinopril | Lisinopril | 180 | 56 |
| Famotidine | Famotidine | 171 | 53 |
| Alprazolam | Alprazolam | 159 | 40 |
| Fluticasone Propionate | Fluticasone Propionate | 149 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 147 | 35 |
| Tramadol Hcl | Tramadol Hcl | 146 | 31 |
| Metoprolol Succinate | Metoprolol Succinate | 144 | 48 |
| Pregabalin | Pregabalin | 130 | 32 |
| Bupropion Xl | Bupropion Hcl | 129 | 37 |
| Ezetimibe | Ezetimibe | 129 | 34 |
| Trazodone Hcl | Trazodone Hcl | 128 | 36 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 127 | 48 |
| Metformin Hcl | Metformin Hcl | 127 | 41 |
| Mounjaro | Tirzepatide | 122 | 19 |
| Buspirone Hcl | Buspirone Hcl | 116 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 116 | 24 |
| Pravastatin Sodium | Pravastatin Sodium | 111 | 32 |
| Hydrochlorothiazide | Hydrochlorothiazide | 110 | 33 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 110 | 35 |
| Meloxicam | Meloxicam | 110 | 34 |
| Simvastatin | Simvastatin | 106 | 31 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 103 | 29 |
| Ropinirole Hcl | Ropinirole Hcl | 97 | 32 |
| Zolpidem Tartrate | Zolpidem Tartrate | 97 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 95 | 36 |
| Synthroid | Levothyroxine Sodium | 92 | 19 |
| Potassium Chloride | Potassium Chloride | 90 | 30 |
| Montelukast Sodium | Montelukast Sodium | 89 | 22 |
| Carvedilol | Carvedilol | 88 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 87 | 27 |
| Mirtazapine | Mirtazapine | 87 | 22 |
| Lorazepam | Lorazepam | 85 | 27 |
| Donepezil Hcl | Donepezil Hcl | 84 | 23 |
| Fluconazole | Fluconazole | 82 | 34 |
| Furosemide | Furosemide | 82 | 29 |
| Methocarbamol | Methocarbamol | 81 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 80 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 79 | 24 |
| Methylprednisolone | Methylprednisolone | 78 | 64 |
| Pioglitazone Hcl | Pioglitazone Hcl | 74 | 21 |
| Sertraline Hcl | Sertraline Hcl | 74 | 20 |
| Eliquis | Apixaban | 70 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 68 | 22 |
| Tizanidine Hcl | Tizanidine Hcl | 68 | 14 |
| Allopurinol | Allopurinol | 63 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 62 | 52 |
| Fenofibrate | Fenofibrate | 62 | 15 |
| Glipizide Er | Glipizide | 61 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 58 | 41 |
| Jardiance | Empagliflozin | 57 | 12 |
| Ondansetron Odt | Ondansetron | 56 | 26 |
| Trulicity | Dulaglutide | 56 | 13 |
| Temazepam | Temazepam | 53 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 52 | 14 |
| Azithromycin | Azithromycin | 51 | 44 |
| Clonazepam | Clonazepam | 51 | suppressed |
| Topiramate | Topiramate | 48 | 11 |
| Clopidogrel | Clopidogrel Bisulfate | 46 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 44 | 13 |
| Mometasone Furoate | Mometasone Furoate | 44 | 27 |
| Amitriptyline Hcl | Amitriptyline Hcl | 41 | 12 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 41 | 17 |
| Januvia | Sitagliptin Phosphate | 41 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 41 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 40 | 13 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 34 |
| Sumatriptan Succinate | Sumatriptan Succinate | 39 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 39 | suppressed |
| Levetiracetam | Levetiracetam | 38 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 25 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 36 | suppressed |
| Memantine Hcl | Memantine Hcl | 34 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 34 | 14 |
| Oxybutynin Chloride | Oxybutynin Chloride | 32 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 31 | 27 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 31 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 31 | suppressed |
| Estradiol | Estradiol | 31 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 31 | suppressed |
| Primidone | Primidone | 31 | 12 |
| Azelastine Hcl | Azelastine Hcl | 30 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 30 | 16 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 30 | 11 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 30 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 30 | suppressed |
| Glipizide | Glipizide | 29 | 11 |
| Metformin Hcl Er | Metformin Hcl | 29 | suppressed |
| Risperidone | Risperidone | 29 | suppressed |
| Glimepiride | Glimepiride | 28 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 27 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 27 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 26 | 16 |
| Valsartan | Valsartan | 26 | suppressed |
| Acyclovir | Acyclovir | 25 | suppressed |
| Levofloxacin | Levofloxacin | 25 | 22 |
| Farxiga | Dapagliflozin Propanediol | 24 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 24 | suppressed |
| Myrbetriq | Mirabegron | 24 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 24 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 24 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 23 | suppressed |
| Haloperidol | Haloperidol | 23 | 12 |
| Latanoprost | Latanoprost | 22 | suppressed |
| Naloxone Hcl | Naloxone Hcl | 22 | 19 |
| Prednisone | Prednisone | 22 | 16 |
| Spironolactone | Spironolactone | 22 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 22 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 21 | 13 |
| Cephalexin | Cephalexin | 20 | 19 |
| Gemtesa | Vibegron | 20 | suppressed |
| Movantik | Naloxegol Oxalate | 20 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 20 | suppressed |
| Vascepa | Icosapent Ethyl | 19 | suppressed |
| Atenolol | Atenolol | 17 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 17 | suppressed |
| Colchicine | Colchicine | 16 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 15 | suppressed |
| Finasteride | Finasteride | 15 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 15 | suppressed |
| Lovastatin | Lovastatin | 15 | suppressed |
| Aripiprazole | Aripiprazole | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Gemfibrozil | Gemfibrozil | 14 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Tradjenta | Linagliptin | 14 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 13 | suppressed |
| Amoxicillin | Amoxicillin | 13 | 12 |
| Calcitriol | Calcitriol | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Ketoconazole | Ketoconazole | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Lidocaine | Lidocaine | 12 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 12 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Valium | Diazepam | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Clobazam | Clobazam | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Hydrocortisone | Hydrocortisone | 11 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 11 | suppressed |
| Novolog | Insulin Aspart | 11 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 11 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $49,546.59 · 23 records | Takeda Pharmaceuticals U.S.A., Inc. | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error